These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 25519926

  • 1. The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology.
    Ferrone CR, Ting DT, Shahid M, Konstantinidis IT, Sabbatino F, Goyal L, Rice-Stitt T, Mubeen A, Arora K, Bardeesey N, Miura J, Gamblin TC, Zhu AX, Borger D, Lillemoe KD, Rivera MN, Deshpande V.
    Ann Surg Oncol; 2016 Jan; 23(1):290-6. PubMed ID: 25519926
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cholangiolar pattern and albumin in situ hybridisation enable a diagnosis of intrahepatic cholangiocarcinoma.
    Brackett DG, Neyaz A, Arora K, Masia R, Mattia A, Zukerberg L, Misdraji J, Goyal L, Zhu AX, Ferrone CR, Yilmaz OH, Deshpande V.
    J Clin Pathol; 2020 Jan; 73(1):23-29. PubMed ID: 31422372
    [Abstract] [Full Text] [Related]

  • 5. Albumin In Situ Hybridization Can Be Positive in Adenocarcinomas and Other Tumors From Diverse Sites.
    Nasir A, Lehrke HD, Mounajjed T, Said S, Zhang L, Yasir S, Shah SS, Chandan VS, Smyrk TC, Moreira RK, Boland Froemming JM, Herrera Hernandez LP, Wu TT, Graham RP.
    Am J Clin Pathol; 2019 Jul 05; 152(2):190-199. PubMed ID: 31107526
    [Abstract] [Full Text] [Related]

  • 6. Detection of Albumin Expression by RNA In Situ Hybridization Is a Sensitive and Specific Method for Identification of Hepatocellular Carcinomas and Intrahepatic Cholangiocarcinomas.
    Lin F, Shi J, Wang HL, Ma XJ, Monroe R, Luo Y, Chen Z, Liu H.
    Am J Clin Pathol; 2018 May 31; 150(1):58-64. PubMed ID: 29746696
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Branched chain in situ hybridization for albumin as a marker of hepatocellular differentiation: evaluation of manual and automated in situ hybridization platforms.
    Shahid M, Mubeen A, Tse J, Kakar S, Bateman AC, Borger D, Rivera MN, Ting DT, Deshpande V.
    Am J Surg Pathol; 2015 Jan 31; 39(1):25-34. PubMed ID: 25353287
    [Abstract] [Full Text] [Related]

  • 9. Decreasing Albumin mRNA Expression in Cholangiocarcinomas along the Bile Duct Tree.
    Albertini E, Chillotti S, Monti G, Malvi D, Deserti M, Degiovanni A, Palloni A, Tavolari S, Brandi G, D'Errico A, Vasuri F.
    Pathobiology; 2024 Jan 31; 91(5):338-344. PubMed ID: 38763129
    [Abstract] [Full Text] [Related]

  • 10. Albumin expression distinguishes bile duct adenomas from metastatic adenocarcinoma.
    Moy AP, Arora K, Deshpande V.
    Histopathology; 2016 Sep 31; 69(3):423-30. PubMed ID: 26841202
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Albumin, filamin-A and cytokeratin 19 help distinguish intrahepatic cholangiocarcinoma from extrahepatic adenocarcinoma.
    Chung YS, Jeon Y, Yoo JE, Chung T, Ryu HJ, Kim H, Rhee H, Park YN.
    Hepatol Int; 2023 Feb 31; 17(1):77-85. PubMed ID: 36253584
    [Abstract] [Full Text] [Related]

  • 14. Differentiation of primary and metastatic clear cell tumors in the liver by in situ hybridization for albumin messenger RNA.
    Oliveira AM, Erickson LA, Burgart LJ, Lloyd RV.
    Am J Surg Pathol; 2000 Feb 31; 24(2):177-82. PubMed ID: 10680884
    [Abstract] [Full Text] [Related]

  • 15. Immunoreactivity of Hep Par 1 in hepatic and extrahepatic tumors and its correlation with albumin in situ hybridization in hepatocellular carcinoma.
    Kakar S, Muir T, Murphy LM, Lloyd RV, Burgart LJ.
    Am J Clin Pathol; 2003 Mar 31; 119(3):361-6. PubMed ID: 12645337
    [Abstract] [Full Text] [Related]

  • 16. Combined hepatocellular-cholangiocarcinoma: a histopathologic, immunohistochemical, and in situ hybridization study.
    Tickoo SK, Zee SY, Obiekwe S, Xiao H, Koea J, Robiou C, Blumgart LH, Jarnagin W, Ladanyi M, Klimstra DS.
    Am J Surg Pathol; 2002 Aug 31; 26(8):989-97. PubMed ID: 12170085
    [Abstract] [Full Text] [Related]

  • 17. The Das-1 immunostain is useful for discriminating metastatic colon adenocarcinoma from cholangiocarcinoma and hepatocellular carcinoma.
    Zimmerman RL, Das KM, Fogt F, Burke M, Murakata LA.
    Oncol Rep; 2002 Aug 31; 9(6):1369-72. PubMed ID: 12375050
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma.
    Park HJ, Kim YK, Park MJ, Lee WJ.
    Abdom Imaging; 2013 Aug 31; 38(4):793-801. PubMed ID: 22829097
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.